Lentiviral vector conferring resistance to mycophenolate mofetil and sensitivity to ganciclovir for in vivo T-cell selection

D. Sangiolo, M. Lesnikova, R. A. Nash, M. C. Jensen, A. Niktine, H. P. Kiem, G. E. Georges*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Several clinical studies of gene-modified T cells have shown limited in vivo function of the cells, immunogenicity of the transgene, and lack of a selective advantage for genemodified T cells. To address these problems, we developed a lentiviral vector (LV) that provides a selectable, proliferative advantage and potentially decreases immunogenicity for transduced T cells. The bicistronic vector expressed two genes linked with an internal ribosomal entry site. One gene is a variant of the inosine monophosphate dehydrogenase 2, inosine monophosphate dehydrogenase (IMPDHIY), conferring resistance to the immunosuppressive drug mycophenolate mofetil (MMF). The other is a suicide gene, herpes simplex virus thymidine kinase (HSV-TK), rendering proliferating cells sensitive to ablation with ganciclovir, fused to the selectable transmembrane marker DCD34 (DCD34/TK). Cells transduced with V-DCD34/TK.IMPDHIY were efficiently enriched by immunomagnetic selection for CD34, proliferated in 0.5-5 μM MMF, and were killed by 0.5 25 μg ml1 ganciclovir. We demonstrate efficient selection and killing of gene-modified cells and suggest LV-ΔCD34/TK.IMPDHIY- transduced T cells could be used to facilitate allogeneic hematopoietic cell engraftment. The expression of IMPDHIY would allow in vivo selection with MMF, and DCD34/TK expression would allow rapid and safe elimination of transduced T cells if raft-versus-host disease developed.

Original languageEnglish (US)
Pages (from-to)1549-1554
Number of pages6
JournalGene therapy
Issue number21
StatePublished - Nov 2007

ASJC Scopus subject areas

  • Genetics
  • Molecular Medicine
  • Molecular Biology


Dive into the research topics of 'Lentiviral vector conferring resistance to mycophenolate mofetil and sensitivity to ganciclovir for in vivo T-cell selection'. Together they form a unique fingerprint.

Cite this